A Stability Indicating RP-HPLC Method Validation for Simultaneous Estimation of Linagliptin and Empagliflozin in Pharmaceutical Dosage Form

Aims: Linagliptin and Empagliflozin are a new medicine combination for the treatment of Diabetes Mellitus, one of humanity’s oldest and most fatal diseases. The goal of this study was to develop and validate a new, quick, sensitive, specific, and stable stability indicating analytical approach for the simultaneous estimation of Linagliptin and Empagliflozin in a fixed…
Read more

February 18, 2022 0